Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alpha Teknova Inc
(NQ:
TKNO
)
4.940
+0.240 (+5.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alpha Teknova Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 22, 2023
Via
Benzinga
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
September 19, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
September 18, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Recap: Alpha Teknova Q1 Earnings
May 10, 2023
Via
Benzinga
Earnings Outlook For Alpha Teknova
March 14, 2023
Via
Benzinga
Teknova Announces New Board Member, Martha J. Demski
August 16, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
August 09, 2023
State-of-the-art facility in Hollister, California is designed to help bioprocessing and gene therapy companies scale from research to clinical production
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
July 26, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
July 20, 2023
Results from the companies’ first collaboration show the successful achievement of more than 85% full AAV with 80-95% recoveries when pairing Sartorius BIA Separations’ monolithic purification platform...
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Alpha Teknova Set to Prosper from Expected Boom in Cell & Gene Therapies: KeyBanc Analyst
July 12, 2023
KeyBanc Capital Markets has initiated coverage on Alpha Teknova Inc (NASDAQ: TKNO) with a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023
July 12, 2023
Via
Benzinga
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
July 11, 2023
First-of-its-kind screening kit now available for AAV8 – along with a suite of high-quality reagents to support the entire AAV workflow – helping gene therapy developers save months in process...
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova to Participate in Upcoming Investor Conference
May 25, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova Reports First Quarter 2023 Financial Results
May 10, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
May 10, 2023
Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
May 09, 2023
On Tuesday, 164 companies hit new 52-week lows.
Via
Benzinga
Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023
May 04, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies
May 02, 2023
State-of-the-art screening kit – available for purchase today – could save months of process development time by helping gene therapy developers to identify the ideal buffer formulations for use during...
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
April 26, 2023
On Wednesday, 345 companies set new 52-week lows.
Via
Benzinga
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
April 26, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
April 24, 2023
On Monday, 147 stocks made new 52-week lows.
Via
Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
April 13, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Teknova Reports Fourth Quarter and Full Year 2022 Financial Results
March 15, 2023
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
April 20, 2023
During Thursday's session, 99 companies made new 52-week lows.
Via
Benzinga
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
March 15, 2023
An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery
From
Alpha Teknova, Inc.
Via
GlobeNewswire
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear.
Via
Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
March 14, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.